Furthermore, Jianpi Huayu Formula downregulates Piezo1 expression and inhibits the PI3K/AKT/mTOR pathway, sensitizing HCC to doxorubicin (Fang et al., 2025). The gene discussed is PIK3CA; the disease is hepatocellular carcinoma.